<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37756598</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1754-8411</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Disease models &amp; mechanisms</Title><ISOAbbreviation>Dis Model Mech</ISOAbbreviation></Journal><ArticleTitle>Sodium butyrate does not protect spinal motor neurons from AMPA-induced excitotoxic degeneration in vivo.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">dmm049851</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1242/dmm.049851</ELocationID><Abstract><AbstractText>Motor neuron (MN) loss is the primary pathological hallmark of amyotrophic lateral sclerosis (ALS). Histone deacetylase 4 (HDAC4) is one of several factors involved in nerve-muscle communication during MN loss, hindering muscle reinnervation, as shown in humans and in animal models of ALS, and may explain the differential progression observed in patients with ALS - rapid versus slow progression. In this work, we inhibited HDAC4 activity through the administration of a pan-histone deacetylase inhibitor, sodium butyrate, in an in vivo model of chronic spinal MN death induced by AMPA-mediated excitotoxicity. We infused AMPA into the spinal cord at low and high doses, which mimic the rapid and slow progression observed in humans, respectively. We found that muscle HDAC4 expression was increased by high-dose infusion of AMPA. Treatment of animals with sodium butyrate further decreased expression of muscle HDAC4, although non-significantly, and did not prevent the paralysis or the MN loss induced by AMPA infusion. These results inform on the role of muscle HDAC4 in MN degeneration in vivo and provide insights for the search for more suitable therapeutic strategies.</AbstractText><CopyrightInformation>&#xa9; 2023. Published by The Company of Biologists Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prior-Gonz&#xe1;lez</LastName><ForeName>Mara</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8474-3829</Identifier><AffiliationInfo><Affiliation>Divisi&#xf3;n de Neurociencias, Instituto de Fisiolog&#xed;a Celular, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico, Circuito exterior s/n, Ciudad Universitaria, Coyoac&#xe1;n, Mexico City 04510, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazo-G&#xf3;mez</LastName><ForeName>Rafael</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-3989-7623</Identifier><AffiliationInfo><Affiliation>Divisi&#xf3;n de Neurociencias, Instituto de Fisiolog&#xed;a Celular, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico, Circuito exterior s/n, Ciudad Universitaria, Coyoac&#xe1;n, Mexico City 04510, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tapia</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-8948-0140</Identifier><AffiliationInfo><Affiliation>Divisi&#xf3;n de Neurociencias, Instituto de Fisiolog&#xed;a Celular, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico, Circuito exterior s/n, Ciudad Universitaria, Coyoac&#xe1;n, Mexico City 04510, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>240817</GrantID><Agency>Consejo Nacional de Ciencia y Tecnolog&#xed;a</Agency><Country/></Grant><Grant><GrantID>IN204516</GrantID><Agency>Direcci&#xf3;n General de Asuntos del Personal Acad&#xe9;mico, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico</Agency><Country/></Grant><Grant><GrantID>240817</GrantID><Agency>Consejo Nacional de Humanidades, Ciencia y Tecnolog&#xed;a</Agency><Country/></Grant><Grant><GrantID>IN204516</GrantID><Agency>Universidad Nacional Aut&#xf3;noma de M&#xe9;xico</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Dis Model Mech</MedlineTA><NlmUniqueID>101483332</NlmUniqueID><ISSNLinking>1754-8403</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>77521-29-0</RegistryNumber><NameOfSubstance UI="D018350">alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>107-92-6</RegistryNumber><NameOfSubstance UI="D020148">Butyric Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018350" MajorTopicYN="N">alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020148" MajorTopicYN="N">Butyric Acid</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Excitotoxicity</Keyword><Keyword MajorTopicYN="N">Histone deacetylase</Keyword><Keyword MajorTopicYN="N">Motor neuron</Keyword><Keyword MajorTopicYN="N">Paralysis</Keyword></KeywordList><CoiStatement>Competing interests The authors declare no competing or financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>27</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>27</Day><Hour>15</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37756598</ArticleId><ArticleId IdType="pmc">PMC10581382</ArticleId><ArticleId IdType="doi">10.1242/dmm.049851</ArticleId><ArticleId IdType="pii">329504</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abe, K., Itoyama, Y., Sobue, G., Tsuji, S., Aoki, M., Doyu, M., Hamada, C., Kondo, K., Yoneoka, T., Akimoto, M.et al. (2014). Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients. Amyotroph. Lateral Scler. Frontotemporal. Degener. 15, 610-617. 10.3109/21678421.2014.959024</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.959024</ArticleId><ArticleId IdType="pmc">PMC4266079</ArticleId><ArticleId IdType="pubmed">25286015</ArticleId></ArticleIdList></Reference><Reference><Citation>Albo, F., Pieri, M. and Zona, C. (2004). Modulation of AMPA receptors in spinal motor neurons by the neuroprotective agent riluzole. J. Neurosci. Res. 78, 200-207. 10.1002/jnr.20244</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.20244</ArticleId><ArticleId IdType="pubmed">15378511</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschenbrenner, D. S. (2023). New drug approved for ALS. Am. J. Nurs. 123, 22-23. 10.1097/01.NAJ.0000911516.31267.67</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.NAJ.0000911516.31267.67</ArticleId><ArticleId IdType="pubmed">36546382</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkin, J. D., Scott, R. L., West, J. M., Lopes, E., Quah, A. K. J. and Cheema, S. S. (2005). Properties of slow- and fast-twitch muscle fibres in a mouse model of amyotrophic lateral sclerosis. Neuromuscul. Disord. 15, 377-388. 10.1016/j.nmd.2005.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2005.02.005</ArticleId><ArticleId IdType="pubmed">15833433</ArticleId></ArticleIdList></Reference><Reference><Citation>Blizzard, C. A., Southam, K. A., Dawkins, E., Lewis, K. E., King, A. E., Clark, J. A. and Dickson, T. C. (2015). Identifying the primary site of pathogenesis in amyotrophic lateral sclerosis - vulnerability of lower motor neurons to proximal excitotoxicity. Dis. Model. Mech. 8, 215-224. 10.1242/dmm.018606</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.018606</ArticleId><ArticleId IdType="pmc">PMC4348560</ArticleId><ArticleId IdType="pubmed">25740331</ArticleId></ArticleIdList></Reference><Reference><Citation>Blizzard, C. A., Lee, K. M. and Dickson, T. C. (2016). Inducing chronic excitotoxicity in the mouse spinal cord to investigate lower motor neuron degeneration. Front. Neurosci. 10, 1-8. 10.3389/fnins.2016.00076</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2016.00076</ArticleId><ArticleId IdType="pmc">PMC4773442</ArticleId><ArticleId IdType="pubmed">26973454</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifacino, T., Provenzano, F., Gallia, E., Ravera, S., Torazza, C., Bossi, S., Ferrando, S., Puliti, A., Van Den Bosch, L., Bonanno, G.et al. (2019). In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 129, 79-92. 10.1016/j.nbd.2019.05.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.05.007</ArticleId><ArticleId IdType="pubmed">31102766</ArticleId></ArticleIdList></Reference><Reference><Citation>Brockington, A., Ning, K., Heath, P. R., Wood, E., Kirby, J., Fusi, N., Lawrence, N., Wharton, S. B., Ince, P. G. and Shaw, P. J. (2013). Unravelling the enigma of selective vulnerability in neurodegeneration: motor neurons resistant to degeneration in ALS show distinct gene expression characteristics and decreased susceptibility to excitotoxicity. Acta Neuropathol. 125, 95-109. 10.1007/s00401-012-1058-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1058-5</ArticleId><ArticleId IdType="pmc">PMC3535376</ArticleId><ArticleId IdType="pubmed">23143228</ArticleId></ArticleIdList></Reference><Reference><Citation>Br&#xfc;gger, V., Duman, M., Bochud, M., M&#xfc;nger, E., Heller, M., Ruff, S. and Jacob, C. (2017). Delaying histone deacetylase response to injury accelerates conversion into repair Schwann cells and nerve regeneration. Nat. Commun. 8, 14272. 10.1038/ncomms14272</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms14272</ArticleId><ArticleId IdType="pmc">PMC5290322</ArticleId><ArticleId IdType="pubmed">28139683</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruneteau, G., Simonet, T., Bauch&#xe9;, S., Mandjee, N., Malfatti, E., Girard, E., Tanguy, M.-L., Behin, A., Khiami, F., Sariali, E.et al. (2013). Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: Potential role in reinnervation ability and disease progression. Brain 136, 2359-2368. 10.1093/brain/awt164</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt164</ArticleId><ArticleId IdType="pubmed">23824486</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruneteau, G., Bauch&#xe9;, S., Gonzalez De Aguilar, J. L., Brochier, G., Mandjee, N., Tanguy, M.-L., Hussain, G., Behin, A., Khiami, F., Sariali, E.et al. (2015). Endplate denervation correlates with Nogo-A muscle expression in amyotrophic lateral sclerosis patients. Annal. Clin. Transl. Neurol. 2, 362-372. 10.1002/acn3.179</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.179</ArticleId><ArticleId IdType="pmc">PMC4402082</ArticleId><ArticleId IdType="pubmed">25909082</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonvicino, D., Felici, R., Ranieri, G., Caramelli, R., Lapucci, A., Cavone, L., Muzzi, M., Di Pietro, L., Bernardini, C., Zwergel, C.et al. (2018). Effects of Class II-selective histone deacetylase inhibitor on neuromuscular function and disease progression in SOD1-ALS mice. Neuroscience 379, 228-238. 10.1016/j.neuroscience.2018.03.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2018.03.022</ArticleId><ArticleId IdType="pubmed">29588251</ArticleId></ArticleIdList></Reference><Reference><Citation>Butchbach, M. E. R., Lumpkin, C. J., Harris, A. W., Saieva, L., Edwards, J. D., Workman, E., Simard, L. R., Pellizzoni, L. and Burghes, A. H. M. (2016). Protective effects of butyrate-based compounds on a mouse model for spinal muscular atrophy. Exp. Neurol. 279, 13-26. 10.1016/j.expneurol.2016.02.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2016.02.009</ArticleId><ArticleId IdType="pmc">PMC4834225</ArticleId><ArticleId IdType="pubmed">26892876</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho, Y. and Cavalli, V. (2012). HDAC5 is a novel injury-regulated tubulin deacetylase controlling axon regeneration. EMBO J. 31, 3063-3078. 10.1038/emboj.2012.160</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2012.160</ArticleId><ArticleId IdType="pmc">PMC3400015</ArticleId><ArticleId IdType="pubmed">22692128</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang, D.-M., Leng, Y., Marinova, Z., Kim, H.-J. and Chiu, C.-T. (2009). Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci. 32, 591-601. 10.1016/j.tins.2009.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2009.06.002</ArticleId><ArticleId IdType="pmc">PMC2771446</ArticleId><ArticleId IdType="pubmed">19775759</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen, T. J., Waddell, D. S., Barrientos, T., Lu, Z., Feng, G., Cox, G. A., Bodine, S. C. and Yao, T.-P. (2007). The histone deacetylase HDAC4 connects neural activity to muscle transcriptional reprogramming. J. Biol. Chem. 282, 33752-33759. 10.1074/jbc.M706268200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M706268200</ArticleId><ArticleId IdType="pubmed">17873280</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahmane, R., Djordjevi&#x10d;, S. and Smerdu, V. (2006). Adaptive potential of human biceps femoris muscle demonstrated by histochemical, immunohistochemical and mechanomyographical methods. Med. Biol. Eng. Comput. 44, 999-1006. 10.1007/s11517-006-0114-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11517-006-0114-5</ArticleId><ArticleId IdType="pubmed">17024467</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimauro, I., Pearson, T., Caporossi, D. and Jackson, M. J. (2012). A simple protocol for the subcellular fractionation of skeletal muscle cells and tissue. BMC Res. Notes 5, 513. 10.1186/1756-0500-5-513</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-0500-5-513</ArticleId><ArticleId IdType="pmc">PMC3508861</ArticleId><ArticleId IdType="pubmed">22994964</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen, A. (2021). The dying forward hypothesis of ALS: tracing its history. Brain Sci. 11, 1-9. 10.3390/brainsci11030300</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11030300</ArticleId><ArticleId IdType="pmc">PMC7997258</ArticleId><ArticleId IdType="pubmed">33673524</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty, M. J. (2019). Amyotrophic lateral sclerosis as a synaptopathy. Neural Regener. Res. 14, 189-192. 10.4103/1673-5374.244782</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.244782</ArticleId><ArticleId IdType="pmc">PMC6301167</ArticleId><ArticleId IdType="pubmed">30530995</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliano, H., Delgado-Morales, R., Sanz-Garcia, A. and Armario, A. (2014). High doses of the histone deacetylase inhibitor sodium butyrate trigger a stress-like response. Neuropharmacology 79, 75-82. 10.1016/j.neuropharm.2013.10.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2013.10.031</ArticleId><ArticleId IdType="pubmed">24212060</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory, J. M., Livesey, M. R., McDade, K., Selvaraj, B. T., Barton, S. K., Chandran, S. and Smith, C. (2020). Dysregulation of AMPA receptor subunit expression in sporadic ALS post-mortem brain. Pathology 250, 67-78. 10.1002/path.5351</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5351</ArticleId><ArticleId IdType="pmc">PMC6973025</ArticleId><ArticleId IdType="pubmed">31579943</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang, M. C., Adimula, A., Birch, D. and Heckman, C. J. (2017). Hyperexcitability in synaptic and firing activities of spinal motoneurons in an adult mouse model of amyotrophic lateral sclerosis. Neuroscience 362, 33-46. 10.1016/j.neuroscience.2017.08.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2017.08.041</ArticleId><ArticleId IdType="pmc">PMC5614896</ArticleId><ArticleId IdType="pubmed">28844763</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouzarides, T. (2007). Chromatin modifications and their function. Cell 128, 693-705. 10.1016/j.cell.2007.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.02.005</ArticleId><ArticleId IdType="pubmed">17320507</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon, B. and Houpt, T. A. (2010). Phospho-acetylation of histone H3 in the amygdala after acute lithium chloride. Brain Res. 1333, 36-47. 10.1016/j.brainres.2010.03.068</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2010.03.068</ArticleId><ArticleId IdType="pmc">PMC2871962</ArticleId><ArticleId IdType="pubmed">20346924</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazo-Gomez, R. and Tapia, R. (2017). Quercetin prevents spinal motor neuron degeneration induced by chronic excitotoxic stimulus by a sirtuin 1-dependent mechanism. Transl. Neurodegener. 6, 31. 10.1186/s40035-017-0102-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-017-0102-8</ArticleId><ArticleId IdType="pmc">PMC5697078</ArticleId><ArticleId IdType="pubmed">29201361</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazo-G&#xf3;mez, R., Ram&#xed;rez-Jarqu&#xed;n, U. N., Tovar-y-Romo, L. B. and Tapia, R. (2013). Histone deacetylases and their role in motor neuron degeneration. Front. Cell. Neurosci. 7, 1-7. 10.3389/fncel.2013.00243</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00243</ArticleId><ArticleId IdType="pmc">PMC3852234</ArticleId><ArticleId IdType="pubmed">24367290</ArticleId></ArticleIdList></Reference><Reference><Citation>Loeffler, J. P., Picchiarelli, G., Dupuis, L. and Gonzalez De Aguilar, J. L. (2016). The role of skeletal muscle in amyotrophic lateral sclerosis. Brain Pathol. 26, 227-236. 10.1111/bpa.12350</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12350</ArticleId><ArticleId IdType="pmc">PMC8029271</ArticleId><ArticleId IdType="pubmed">26780251</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino, G., Piccininni, M., Marin, B., Nichols, E., Abd-Allah, F., Abdelalim, A., Alahdab, F., Asgedom, S. W., Awasthi, A., Chaiah, Y.et al. (2018). Global, regional, and national burden of motor neuron diseases 1990&#x2013;2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 17, 1083-1097. 10.1016/S1474-4422(18)30404-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30404-6</ArticleId><ArticleId IdType="pmc">PMC6234315</ArticleId><ArticleId IdType="pubmed">30409709</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateen, F. J., Carone, M. and Sorenson, E. J. (2010). Patients who survive 5 years or more with ALS in Olmsted County, 1925-2004. J. Neurol. Neurosurg. Psychiatr. 81, 1144-1146. 10.1136/jnnp.2009.201251</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.201251</ArticleId><ArticleId IdType="pmc">PMC2946435</ArticleId><ArticleId IdType="pubmed">20627966</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohan, R., Tosolini, A. P. and Morris, R. (2015). Segmental distribution of the motor neuron columns that supply the rat hindlimb: a muscle/motor neuron tract-tracing analysis targeting the motor end plates. Neuroscience 307, 98-108. 10.1016/j.neuroscience.2015.08.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.08.030</ArticleId><ArticleId IdType="pubmed">26304758</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohgomori, T., Yamasaki, R., Takeuchi, H., Kadomatsu, K., Kira, J.-I. and Jinno, S. (2017). Differential involvement of vesicular and glial glutamate transporters around spinal &#x3b1;-motoneurons in the pathogenesis of SOD1G93A mouse model of amyotrophic lateral sclerosis. Neuroscience 356, 114-124. 10.1016/j.neuroscience.2017.05.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2017.05.014</ArticleId><ArticleId IdType="pubmed">28526579</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni, S., Macklin, E. A., Hendrix, S., Berry, J. D., Elliott, M. A., Maiser, S., Karam, C., Caress, J. B., Owegi, M. A., Quick, A.et al. (2020). Trial of sodium phenylbutyrate&#x2013;taurursodiol for amyotrophic lateral sclerosis. N. Engl. J. Med. 383, 919-930. 10.1056/NEJMoa1916945</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1916945</ArticleId><ArticleId IdType="pmc">PMC9134321</ArticleId><ArticleId IdType="pubmed">32877582</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri, S., Kiaei, M., Kipiani, K., Chen, J., Calingasan, N. Y., Crow, J. P. and Beal, M. F. (2006). Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 22, 40-49. 10.1016/j.nbd.2005.09.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2005.09.013</ArticleId><ArticleId IdType="pubmed">16289867</ArticleId></ArticleIdList></Reference><Reference><Citation>Pigna, E., Simonazzi, E., Sanna, K., Bernadzki, K. M., Proszynski, T., Heil, C., Palacios, D., Adamo, S. and Moresi, V. (2019). Histone deacetylase 4 protects from denervation and skeletal muscle atrophy in a murine model of amyotrophic lateral sclerosis. EBioMedicine 40, 717-732. 10.1016/j.ebiom.2019.01.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2019.01.038</ArticleId><ArticleId IdType="pmc">PMC6414308</ArticleId><ArticleId IdType="pubmed">30713114</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram&#xed;rez-Jarqu&#xed;n, U. N. and Tapia, R. (2016). Neuropathological characterization of spinal motor neuron degeneration processes induced by acute and chronic excitotoxic stimulus in vivo. Neuroscience 331, 78-90. 10.1016/j.neuroscience.2016.06.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2016.06.021</ArticleId><ArticleId IdType="pubmed">27320208</ArticleId></ArticleIdList></Reference><Reference><Citation>Santa-Cruz, L. D., Guerrero-Castillo, S., Uribe-Carvajal, S. and Tapia, R. (2016). Mitochondrial dysfunction during the early stages of excitotoxic spinal motor neuron degeneration in vivo. ACS Chem. Neurosci. 7, 886-896. 10.1021/acschemneuro.6b00032</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.6b00032</ArticleId><ArticleId IdType="pubmed">27090876</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw, P. J. and Eggett, C. J. (2000). Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis. J. Neurol. Suppl. 247, I17-I27. 10.1007/BF03161151</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03161151</ArticleId><ArticleId IdType="pubmed">10795883</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang, H., Macpherson, P., Marvin, M., Meadows, E., Klein, W. H., Yang, X.-J., Goldman, D. and Forscher, P. (2009). A histone deacetylase 4/myogenin positive feedback loop coordinates denervation-dependent gene induction and suppression. Mol. Biol. Cell 20, 1120-1131. 10.1091/mbc.e08-07-0759</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e08-07-0759</ArticleId><ArticleId IdType="pmc">PMC2642751</ArticleId><ArticleId IdType="pubmed">19109424</ArticleId></ArticleIdList></Reference><Reference><Citation>Tovar-y-Romo, L. B., Zepeda, A. and Tapia, R. (2007). Vascular endothelial growth factor prevents paralysis and motoneuron death in a rat model of excitotoxic spinal cord neurodegeneration. J. Neuropathol. Exp. Neurol. 66, 913-922. 10.1097/nen.0b013e3181567c16</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/nen.0b013e3181567c16</ArticleId><ArticleId IdType="pubmed">17917585</ArticleId></ArticleIdList></Reference><Reference><Citation>Tovar-y-Romo, L. B., Santa-Cruz, L. D. and Tapia, R. (2009). Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis. Mol. Neurodegener. 4, 31. 10.1186/1750-1326-4-31</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-4-31</ArticleId><ArticleId IdType="pmc">PMC2720968</ArticleId><ArticleId IdType="pubmed">19619317</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh, M. E., Bhattacharya, A., Liu, Y. and Van Remmen, H. (2015). Butyrate prevents muscle atrophy after sciatic nerve crush. Muscle Nerve 52, 859-868. 10.1002/mus.24622</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24622</ArticleId><ArticleId IdType="pubmed">25727783</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Z., Qin, G. and Zhao, T. C. (2014). HDAC4: mechanism of regulation and biological functions. Epigenomics 6, 139-150. 10.2217/epi.13.73</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/epi.13.73</ArticleId><ArticleId IdType="pmc">PMC4380265</ArticleId><ArticleId IdType="pubmed">24579951</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams, A. H., Valdez, G., Moresi, V., Qi, X., Mcanally, J., Elliott, J. L., Bassel-Duby, R., Sanes, J. R. and Olson, E. N. (2009). MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 326, 1549-1554. 10.1126/science.1181046</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1181046</ArticleId><ArticleId IdType="pmc">PMC2796560</ArticleId><ArticleId IdType="pubmed">20007902</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, H., Xiong, W. C. and Mei, L. (2010). To build a synapse: signaling pathways in neuromuscular junction assembly. Development 137, 1017-1033. 10.1242/dev.038711</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.038711</ArticleId><ArticleId IdType="pmc">PMC2835321</ArticleId><ArticleId IdType="pubmed">20215342</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>